Andrea A. Ravelli

Bologna, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

IconicITA: Iconicity ratings of the Italian affective lexicon.

IconicITA: Iconicity ratings of the Italian affective lexicon.

Journal: PloS one

Published: May 23, 2025

Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.

Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 15, 2025

Specificity ratings for English data.

Specificity ratings for English data.

Journal: Cognitive processing

Published: January 31, 2024

CONcreTEXT norms: Concreteness ratings for Italian and English words in context.

CONcreTEXT norms: Concreteness ratings for Italian and English words in context.

Journal: PloS one

Published: March 24, 2023

Linguistic profile automated characterisation in pluripotential clinical high-risk mental state (CHARMS) conditions: methodology of a multicentre observational study.

Linguistic profile automated characterisation in pluripotential clinical high-risk mental state (CHARMS) conditions: methodology of a multicentre observational study.

Journal: BMJ open

Published: March 22, 2023

Health professionals' perception of appropriateness of care: a qualitative study in Italian pediatric hospices.

Health professionals' perception of appropriateness of care: a qualitative study in Italian pediatric hospices.

Journal: Acta bio-medica : Atenei Parmensis

Published: October 26, 2020

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.

The anti-tumor efficacy of CDK4/6 inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 05, 2017

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

Combined Inhibition of CDK4/6 and PI3K/AKT/mTOR Pathways Induces a Synergistic Anti-Tumor Effect in Malignant Pleural Mesothelioma Cells.

Journal: Neoplasia (New York, N.Y.)

Published: April 07, 2017

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: April 06, 2017

Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.

Enhanced efficacy of AKT and FAK kinase combined inhibition in squamous cell lung carcinomas with stable reduction in PTEN.

Journal: Oncotarget

Published: November 25, 2016

CDK4/6 inhibitors in HER2-positive breast cancer.

CDK4/6 inhibitors in HER2-positive breast cancer.

Journal: Critical reviews in oncology/hematology

Published: November 23, 2016

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials.

Journal: Medicine

Published: October 28, 2016

Showing 1-12 of 22

Last Updated: 09/26/2026